STRO - SUTRO BIOPHARMA, INC.
10.75
0.370 3.442%
Share volume: 40,041
Last Updated: 12-24-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$10.38
0.37
0.04%
View ratios
| Fiscal Date | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 03-25-2024 | 05-13-2024 | 08-13-2024 | 11-13-2024 | 03-13-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | |
| Total revenue | 113.721 M | 13.008 M | 25.706 M | 8.520 M | 14.809 M | 17.399 M | 63.745 M | 9.693 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 113.721 M | 13.008 M | 25.706 M | 8.520 M | 14.809 M | 17.399 M | 63.745 M | 9.693 M | |
| -88.56% | 97.62% | -66.86% | 73.81% | 17.49% | 266.37% | -84.79% | |||
| Operating expenses | 70.569 M | 69.599 M | 74.391 M | 76.439 M | 80.067 M | 64.870 M | 48.668 M | 48.594 M | |
| Selling general and admin | 16.804 M | 12.721 M | 12.371 M | 14.331 M | 9.030 M | 13.273 M | 10.343 M | 8.741 M | |
| Research and development | 53.765 M | 56.878 M | 62.020 M | 62.108 M | 71.037 M | 51.597 M | 38.325 M | 39.853 M | |
| Total expenses | 70.569 M | 69.599 M | 74.391 M | 76.439 M | 80.067 M | 85.913 M | 67.090 M | 58.152 M | |
| -1.37% | 6.89% | 2.75% | 4.75% | 7.30% | -21.91% | -13.32% | |||
| Operating income | 43.152 M | -56.591 M | -48.685 M | -67.919 M | -65.258 M | -68.514 M | -3.345 M | -48.459 M | |
| Ebit | 43.152 M | -56.591 M | -43.877 M | -67.919 M | -73.745 M | -68.514 M | -3.345 M | -48.459 M | |
| Pretax income | 46.872 M | -58.213 M | -48.010 M | -48.787 M | -70.088 M | -75.968 M | -11.517 M | -56.857 M | |
| -224.20% | -17.53% | 1.62% | 43.66% | 8.39% | -84.84% | 393.68% | |||
| Income tax | 15.807 M | 0.000 | 8.000 K | 0.000 | 2.355 M | 0.000 | -18.000 K | 0.000 | |
| Net income basic | 31.065 M | -58.213 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -287.39% | 100.00% | ||||||||
| Net income | 31.065 M | -58.213 M | -48.018 M | -48.787 M | -72.443 M | -75.968 M | -11.499 M | -56.857 M | |
| -287.39% | 17.51% | -1.60% | -48.49% | -4.87% | 84.86% | -394.45% |